• Boderline mucinous cystadenoma as the origin of pseudomyxoma peritonei (Presentation of a clinical case)
To content

Boderline mucinous cystadenoma as the origin of pseudomyxoma peritonei (Presentation of a clinical case)

HEALTH OF WOMAN. 2018.1(127):73–76; doi 10.15574/HW.2018.127.73

Dronova V. L. , Dronov O. I. , Roschyna L. O. , Bubliieva O. I.
SI «Institute of Pediatrics, Obstetrics and Gynecology of the National Academy of Medical Sciences of Ukraine», Kiev
National Medical University named after O.O. Bohomoltsya, Kyiv
Center for Surgery of the liver, pancreas and bile ducts named after VS Zemskova, Kiev

Peritoneal pseudomixome (PMP) is a rare clinical condition characterized by a localized or generalized accumulation of gelatin-like content, associated in most cases with mucinous tumors of the digestive tract, and more rarely ovaries.
Based on the presentation of the clinical case of MBP caused by ovarian border neoplasia, the effect of cytoreduction on the further course of the disease as an independent treatment method was analyzed.
The clinical case presented in this article reflects a rare combination of borderline ovarian tumor with PMP. The effectiveness of performing cytoreductive surgery has been proved, which calls into question the advisability of chemotherapy in patients with tumors of a potentially low degree of malignancy.
Key words: borderline mucinous cystadenoma, pseudomyxoma peritonei, debulking.

REFERENCES

1. Abdullaev AG, Polotsky BE, Davydov MI. 2013. Modern approaches to the treatment of pseudo-myxoma of the peritoneum. Russian Oncology Journal 5.

2. Ferreira CR, Carvalho JP, Soares FA, Siqueira SAC, Carvalho FM. 2008. Mucinous ovarian tumors associated with pseudomyxoma peritonei of adenomucinosis type: immunohistochemical evidence that they are secondary tumors. Int.J. Gynecol.Cancer.:59-65.

3. Petrus Järvinen. 2014. Diagnosis and Treatment of Pseudomyxoma Peritonei. Department of Surgery. Helsinki University Central Hospital Faculty of Medicine, University of Helsinki.

4. Moran B, Baratti D, Yan TD et al. 2008. Consensus statement on the loco-regional treatment of appendiceal mucinous neoplasms with peritoneal dissemination (pseudomyxoma peritonei). J. Surg. Oncol. 98:277-282. https://doi.org/10.1002/jso.21054; PMid:18726894

5. Yоnemura Y, Kawamura T, Bandоuetal E. 2007. The natural histоry оf free сanсer сells in the рeritоneal сavity. Reсent Results Сanсer Res. 169:11-23.

6. Ronnett BM, Shmookler BM, Sugarbaker PH, Kurman RJ. 1997. Pseudomyxoma peritonei: new concepts in diagnosis, origin, nomenclature, relationship to mucinous borderline (low malignant potential) tumors of the ovary. In: Fechner RE, Rosen PP, eds. Anatomic Pathology. Chicago: ASCP Pres.: 197-336.

7. Carr NJ, Sobin LH. 2010. Adenocarcinoma of the appendix. In: Bosman FT, Carneiro F, Hruban RH et. аl., eds. WHO classification of tumors of the digestive system. Lyon, IARC.: 122-125.

8. Carr NJ, Cecil T, Mohamed F et al. 2016. A consensus for classification and pathologic reporting of pseudomyxoma peritonei and associated appendiceal neoplasia. The results of the Peritoneal Surface Oncology Group International (PSOGI) modified Delphi process. Am. J. Surg. Pathol. 40(1):14-26.

9. Wong RJ, De Cosse JJ. 1990. Cytoreductive surgery. J. Surg. Gynecol. Obstet. 170(3):276-281.

10. Gilly FN, Carry PY, Sayag AC, Brachet A, Panteix G, Salle B et al. 1994. Regional chemotherapy (with Mitomycic C) and intraoperative hyperthermia in abdominal cancer with peritoneal can-ceromatosis. Hepato gastroenterology: 12- 49.

11. Pranesh NI, Menasce LP, Wilson MS, O'Dwyer ST. 2005, Oct. Pseudomyxoma peritonei: unusual origin from anovarian mature cysticteratoma. J Clin Pathol. 58(10):11-157.